Introduction: Piperine is a compound that has many health benefits, but piperin has toxic effects that endanger the human body. The purpose of this study was to determine the toxic dose of subchronic piperine administration using histology of the liver, kidneys, and lungs of mice (Mus musculus L).Method: This is a quasi-experimental research with posttest only control group design. Thirty male BALB/c mice were divided into five groups. Piperine was administered orally to the mice. The normal control group and four treatment groups at dosage of 17.5, 35, 70, and 140 mg/kg body weight for 21 days. At the day-22, the liver, kidneys, and lungs were removed and prepared using the HE staining technique. Scores of liver, kidney, and lung damage are recorded. The data was analyzed using one-way ANOVA with the post hoc Tukey test.Result: The liver histological damage score after administration of piperine doses of 35, 70, and 140 mg/kg significantly different from the control group. The kidney and lung damage scores after 140 mg/kg administration showed significant differences from the control group. The conclusion is piperine at dosage of 35, 70, and 140 mg/kg was toxic to the liver, and piperine at doses of 140 mg/kg was toxic to the kidney and lung histology of BALB/c mice.Conclusion: Piperine should not be used at doses of 35 mg/kg body weight or larger.
Piperine is an alkaloid found in the plants of the Piperaceae family, such as Piper nigrum and Piper retrofractum. These two plants are commonly used as flavoring agents in daily meals. The piperine extract is reported to be effective in inhibiting the growth of colon cancer cells in laboratory experiments. Between 35-77% of colon cancer cases are caused by excessive expression of the epidermal growth factor receptor. In developing a new compound for commercial drugs, a study of the compound affinity to the receptor is necessary. Hence, the purpose of this study was to comprehensively evaluate the affinity of piperine to the colon cancer receptor using molecular docking software. The AutoDock software was used as a tool for the analysis. Three compounds were analyzed, i.e., the tested ligand (piperine), a native ligand (N-acetyl-D-glucosamine), and a positive control ligand (Gefitinib). Further, the binding score of piperine to the receptor was compared to the binding score of native ligands and positive control ligands. The binding score of the three compounds was found to be -3.82 kcal/mole (piperine), -4.16 kcal/mole (Gefitinib), and -3.75 kcal/mole (N-acetyl-D-glucosamine). It can therefore be concluded that there is a similar affinity between piperine and the control ligand. Therefore, piperine can be recommended and developed as a new drug for colon cancer treatment. Keywords: piperine, in silico, colon cancer, molecular docking
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.